He holds a degree in Medicine and Surgery from the Autonomous University of Barcelona, is a Specialist in Clinical Pharmacology, and a Professor at the UAB.

He has been Chief Clinical Officer of the Hospital del Mar in Barcelona and has subsequently spent his career in important positions in the public sector: He has been director General of the National Plan on Drugs in the Ministry of Health, Undersecretary of the Ministry of Culture, Undersecretary of the Ministry of Social Affairs, and Senior Expert in the General Secretariat of the European Commission. He was also Delegate in Madrid of the Government of the Generalitat de Catalunya. His experience in the private sector has mainly been in the ICT, Health, and Renewable Energy sectors. He has been Vice-President of Terra Lycos, President of Eolia Tarraco, member of the Advisory Board of Indra, promoter of the Telemedicine company eDiagnostic, and member of the board of directors of Mémora

Santiago de Torres was re-elected as executive director on December 10, 2021 and his term of office runs until December 10, 2025.

She holds a degree in Law and a master’s degree in Marketing. She has extensive experience in the management of biotechnology and oncology companies at a national and international level.

Before joining Atrys, she spent eight years as CEO of PharmaMar (a biopharmaceutical R+D+i company) and five years as CFO of the Zeltia Group.

Isabel Lozano was re-elected as executive director on December 10, 2021 and her term of office runs until December 10, 2025.

He holds a degree in Economics and Actuarial and Financial Sciences from the University of Barcelona, and a master’s degree in Financial Management from ESADE.

He was CFO of Oryzon Genomics, S.A. from 2003 to 2007.

He is currently CEO of Inveready Asset Management, S.G.E.C.R., S.A. and Chairman of Grupo Financiero Inveready, companies of which he has been a founding partner and major shareholder.

Member of the Board of Directors of more than 30 companies such as Masmóvil Ibercom, S.A., Agile Contents, S.A., Oryzon Genomics, S.A., Interiorvista, S.L., Palo Biofarma, S.L. or Grupo Natac, S.L.

He has actively participated in dozens of corporate transactions such as the sale of Passwordbank Technologies, S.L., the purchase of Pepephone by Masmóvil or the sale of Indisys, S.L. to Intel.

José Mª Echarri was elected as a proprietary director of Atrys on July 22, 2021 and re-elected as a proprietary director of Atrys, representing Inveready Convertible Finance Capital FCR, on December 10, 2021 and his term of office runs until December 10, 2025.

At the end of February 16, 2023, Jose Mª Echarri held 100 shares of Atrys Health, S.A.

He holds a degree in Law and a master’s degree from Instituto de Empresa.

General Secretary of Grupo Caser, where he also holds, among others, the position of Chairman of Caser Residencial S.A. and Chairman of the Board of Directors of Hospital Parque.

He was appointed director of Atrys on behalf of Grupo Caser on May 25, 2018.

Fernando de Lorenzo was re-elected as a proprietary director of Atrys, representing Grupo Caser, on June 25, 2018 and his term of office runs until May 25, 2024.

He holds a degree in Law from the Complutense University of Madrid and a master’s degree in Science from the University of Wales, Institute of Science and Technology (UWIST).

Chief Executive Officer and founding partner of Geniova Technologies, a dental company owned by the Swiss multinational Straumann Group.

From 1986 to 1992 he was Vice President of Bankers Trust Company Sucursal en España. From 1992 to 2008 he was founding partner and Managing Director of Bridgepoint Capital in Spain.

Since 2008 he dedicates part of his time to entrepreneurship, promoting and participating as an investor in several consumer companies and technology start-ups. He is also Senior Advisor at Avior, a 100% independent private equity firm focused on investing in Spanish companies.

Antonio Baselga was appointed proprietary director of Atrys, representing Onchena S.L., on October 17, 2019 and his term of office runs until October 17, 2025.

As of the close of February 16, 2023, Antonio Baselga de la Vega holds 7,000 shares of Atrys Health, S.A.

Manuel Guerrero Maldonado holds a degree in Economics from the Complutense University of Madrid. He also holds an Executive MBA from the IESE Business School of the University of Navarra.

He has developed his professional career at Deutsche Bank, Barclays Bank (Head of the Restructuring Department), H.I.G. Capital (Director of Bayside Capital Iberia) and Ben Oldman Partners (Managing Director), in the areas of direction, analysis and management of investments, capital markets and debt.

He is currently Chief Investment Officer of Ion Ion.

He was appointed proprietary director of Atrys, representing Ion Ion S.L., by the board held on January 30, 2023, by co-optation procedure.

She holds a degree in Law from the University of Barcelona, a postgraduate degree in Labour Law, and a PDG (General Management Programme) qualification from IESE Business School.

She began her professional career at Grupo Godó in 1995, in the Sales, Finance and finally Controlling departments. Anabel López Porta joined Fersa Energías Renovables in 2004 as Assistant General Manager and participated in its IPO in May 2007. Throughout her career at Fersa she participated in the development of the portfolio of power generation projects as well as in the execution of the divestment plans of these projects, both nationally and internationally.

Appointed Chief Operating Officer in 2011, she was directly involved in all corporate operations of the company and assumed the General Management in July 2015, integrally managing the sale operation of the Fersa group that culminated in a takeover bid process by Audax Energía, S.A. Subsequently, in 2019, he participated directly in the reverse merger operation between Audax Energía and Fersa Energía Renovables, resulting in Grupo Audax Renovables, an independent energy group whose activities are focused on the production of 100% renewable energy, as well as the supply of 100% renewable electricity and gas.

He is currently a member of the board of directors and of the audit, nomination and remuneration committees of Audax Renovables. She is also a member of the board of directors of Ezentis and of its audit committee.

Anabel López was appointed proprietary director of Atrys, representing Excelsior Times S.L., on December 10, 2021 and her term of office runs until December 10, 2025.

She was a founding partner of Mediaworks, S.A., an advertising media centre, for 11 years, having formed part of the energy group Audax Energía since its inception in 2008.

Throughout her career, in the Audax group she has held positions of responsibility related to the areas of administration, finance and human resources, which has given her a transversal vision of the business. Since 2016 she led the development and expansion of the Audax group’s subsidiary in Italy where since 2018 she has also been a member of the Board.

Subsequently, in 2019 she participated directly in the reverse merger operation between Audax Energía and Fersa Energía Renovables, resulting in the Audax Renovables Group, an independent energy group whose activities focus on the production of 100% renewable energy, as well as the supply of 100% renewable electricity and gas.

She is currently a Corporate Director and Director of Audax Renovables.

Mª Rosa González was appointed proprietary director of Atrys, representing Excelsior Times S.L., on June 28, 2021 and was re-elected as proprietary director representing the same on December 10, 2021, and has a term of office until December 10, 2025.

She holds a degree in industrial engineering from the Polytechnic University of Catalonia (UPC), and an MBA from IESE Business School.

After starting her career at Bank of America in the late 1980s, she joined Nissan in 1991 and spent five years as its Chief Financial Officer. In 1996, she became General Manager of Radio Televisión Española (RTVE) and in 1999 she was appointed CEO of Grupo Planeta 2010. In 2008 she became Partner of the headhunting firm Seeliger y Conde, and maintained that role until 2020.

She has combined her roles in these and other organizations with her work as an independent director in companies such as Atresmedia (2009-2021), Repsol (2021) or Banco Sabadell (2015), and in the last two, respectively, she is a member of the appointments and remuneration committees and chairs the remuneration committee. She has also been a director of Instituto Catalán de Finanzas, Abantia and Service Point, among other companies.

Aurora Catá has also chaired Barcelona Global since 2020 and is also a trustee of the Cellnex Foundation.

Aurora Catá was appointed independent director of Atrys on November 4, 2021 and was re-elected on December 10, 2021, and her term of office runs until December 10, 2025.

As of the close of business on February 16, 2023, Aurora Catá holds 15,789 shares of Atrys Health, S.A.

He holds a degree in Law from the University of Cantabria and has taken several courses at IESE and the New York Institute of Finance.

He served as director of internal audit for the Banco Santander group in the United States. He was manager of the same Bank in Bolivia, director with investors, analysts and investors in New York and executive vice president in Colombia until 2005.

Member since 2015 of the advisory board for LatAm of Howden, advisor to BNP Cardif Mexico, and advisor to El Corte Inglés among others. He is managing partner of Negozia S.A. and Senior Advisor at Coltefinanciera and PMGroup.

Jaime Cano was elected independent director of Atrys on June 24, 2016 and re-elected independent director of Atrys on June 28, 2022, and his term of office runs until June 28, 2026.

As of May 30, 2023, Jaime Cano holds 25,000 shares of Atrys Health, S.A.

She holds a degree in Law from the University of Valladolid and a Master’s degree in European Politics from the College of Bruges and was Senior Associate at St Antony’s College, Oxford.

She began her career holding various positions in the institutional field as an advisor in commercial law and economic relations for the European Union and the British Government. Subsequently, Miriam worked as a partner in several renowned international law firms such as DLA Piper and Dechert LLP. She has also held relevant positions on the boards of national and international listed companies, becoming a director of Acciona; Chair of the Audit and Remuneration Committees of UBS Limited in the UK; Chair of the Audit and Risk Committees of UBS Spain and and Vice-Chair of UBS ESE. She has been an adjunct professor at Stanford University. Miriam is currently founder of España Mejor, Inspiring Girls and Altius (an Africa-focused law firm), a member of the panel of international trade arbitrators of the European Union and a member of the Diversity Council of Toyota Europe, among others.

Miriam González was elected independent director of Atrys on June 28, 2023.

He holds a degree in Law from the Complutense University of Madrid, 1995. LL.M. from Leibniz University Hannover (Germany), 1996; Advanced Programme in
Telecommunications, Media and Information Technology Law, Instituto de Empresa, 2001; American Law Programme, Columbia University, New York, 2009. 

Founding partner of Castañeda Abogados (2002). Secretary of the Board of Directors of numerous companies belonging to Spanish and international groups, including Masmovil Ibercom, the fourth largest telecommunications operator in Spain, Xfera Consumer Finance EFC, Kreab Iberia or Minerals Technologies, he has more than 25 years of experience in advising in the field of corporate law.

Alberto Castañeda was appointed non-director secretary on May 17, 2018.

She holds a degree in Law and Business Administration and Management (ADE) from the Universidad Pontificia de Comillas (ICADE E-3). She holds a master’s degree in International Legal Studies (LL.M) from Georgetown University (Washington DC).

Gabriela is the legal head of the entire Atrys Group. Prior to joining Atrys, she worked in different national and international law firms (Cuatrecasas, Linklaters and Pinsent Masons) specializing in corporate and M&A law.

She joined Atrys in September 2020 and was appointed vice-secretary non-counselor on October 27, 2020.